Skip to content

Evaluation of safety and efficacy of INOVOSENSE SHINE EXO PLUS gel containing hyaluronic acid and conditioned media for improvement of face skin hydration and elasticity

Evaluation of safety and efficacy of INOVOSENSE SHINE EXO PLUS gel containing hyaluronic acid and conditioned media for improvement of face skin hydration and elasticity

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250308064973N2
Enrollment
20
Registered
2025-04-28
Start date
2025-04-12
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Hydration. Changes in skin texture

Interventions

Intervention group: INOVOSENSE SHINE EXO PLUS mesogel injection for improvement of face skin hydration and elasticity.The products are in the 2 ml prefilled sterilized syringe, which contains: Hyalur

Sponsors

Medisa Ara Gostar Iranian company
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: 25 - 60 Years women and men The visible signs of dryness and roughness of the skin, and reduced skin elasticity.

Exclusion criteria

Exclusion criteria: Any cosmetic facial procedures during the last 6 months Autoimmune or immune deficiency diseases presence of any active inflammation or infection. Allergy to HA or lidocaine Pregnancy and breastfeeding

Design outcomes

Primary

MeasureTime frame
Stratum corneum hydration. Timepoint: Before the intervention and 4 weeks after the last injection. Method of measurement: Corneometry.;Skin elasticity. Timepoint: Before the intervention and 4 weeks after the last injection. Method of measurement: Cutometry.;Transepidermal water loss. Timepoint: Before the intervention and 4 weeks after the last injection. Method of measurement: Tewametry.

Secondary

MeasureTime frame
Side effects. Timepoint: Before the intervention and 4 weeks after the last injection. Method of measurement: Based on patient's comments.;Signs of skin aging include lines and wrinkles. Timepoint: Before the intervention and 4 weeks after the last injection. Method of measurement: GAIS scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Nasimi

Tehran University of Medical Sciences

nsm.maryam@gmail.com+98 21 5563 0223

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026